Stock data
AEON Biopharma, Inc. (AEON)
AEON Biopharma, Inc. (AEON) reported net income of -US$39.22M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$12.80M | -US$39.22M | — |
| 2024 | — | — | US$72.98M | US$42.01M | — |
| 2022 | — | — | -US$48.43M | -US$52.56M | — |
| 2021 | — | — | -US$1.94M | US$8.20M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$1.16M | — |
| 2026-03-31 | — | -US$11.79M | — |
| 2025-12-31 | — | -US$37.14M | — |
| 2025-09-30 | — | -US$4.54M | — |
| 2025-06-30 | — | -US$6.64M | — |
| 2025-03-31 | — | US$9.10M | — |
| 2024-12-31 | — | US$2.08M | — |
| 2024-09-30 | — | -US$6.17M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.